aTyr Pharma (ATYR)

• Market cap: $86.5M
• 1 day: 3.79%
• 5 days: 24.32%
• 1 month: 18.5%
• 3 months: -0.59%
• 6 months: -82.13%
• Year to date: 16.3%
• 1 year: -76.4%
• 5 years: -76.65%
• 10 years: -98.85%
• Sector: Healthcare
• Industry: Biotechnology

About: aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Employees: 59